Kiniksa is a biopharmaceutical company focused on discovering, developing and commercializing therapeutic medicines for autoimmune diseases.
Business Model:
Revenue: $177M
Employees: 201-500
Address: 100 Hayden Avenue
City: Lexington
State: MA
Zip: 02421
Country: US
Kiniksa is a biopharmaceutical company focused on discovering, developing and commercializing therapeutic medicines for autoimmune diseases.
Contact Phone:
+17814319100
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/23/2018
Ticker Symbol:
KNSA
IPO Price:
$18/share
Amount Raised:
$153M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2018 | Series C | 7 | $200M |
Fidelity Cormorant Asset Management Sofinnova Investments Deerfield Baker Brothers Advisors LLC Venrock Healthcare Capital Partners ArrowMark Partners Baker Brothers Advisors LLC Fidelity Cormorant Asset Management Sofinnova Investments Deerfield Baker Brothers Advisors LLC Venrock Healthcare Capital Partners ArrowMark Partners Baker Brothers Advisors LLC |
3/2017 | Series B | 1 | $40M |
Baker Brothers Advisors LLC Baker Brothers Advisors LLC Baker Brothers Advisors LLC Baker Brothers Advisors LLC |
1/2019 | IPO | - | 5/2020 | Post-IPO Equity | $80M | 3/2019 | Post-IPO Equity | $8.8M | 10/2015 | Series A | 1 | $80M |
Baker Brothers Advisors LLC Baker Brothers Advisors LLC Baker Brothers Advisors LLC Baker Brothers Advisors LLC |
1/2019 | IPO | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|